News about the NHS allocating £10m in funding for a Puberty Blocker trial is welcome and long overdue. However, it's hard to see how any of the evidence produced from this study will directly address many of the concerns that were raised in the Cass Review. 

We had a wonderful couple of days at the Gender Identity Skills Training event in Kilkenny on 5 & 6 March. I was delighted to connect with the 35 other healthcare professionals, experts by experience and community group representatives in attendance.

As a clinical psychologist specialising in transgender healthcare, I have become increasingly alarmed by the systematic attempts to use politics to restrict access to essential medical care for transgender individuals. 

In a troubling move, the Trump administration recently announced plans to remove terms like “gender,” “assigned at birth,” and “queer” from the federal lexicon. Under the guise of a supposed return to traditional values, this policy effectively erases the identities of millions of people who don’t fit within the stereotypical boxes of outdated, binary gender norms.